Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMZEEQ with oral isotretinoin in moderate to severe acne vulgaris
NCT04940767Phase 4Completed
- Start
- Jun 2021
- Primary completion
- Apr 2023
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of zilxi in acne vulgaris. Started Jun 2021; status: completed.
02
Drugs
zilxi
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT04940767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04940767.